Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.Business Wire • 01/30/25
DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?Zacks Investment Research • 01/21/25
DexCom Stock Up Following Strong Preliminary Q4 Results & 2025 OutlookZacks Investment Research • 01/14/25
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 OutlookBusiness Wire • 01/13/25
Billionaire Chase Coleman III Completely Sells Out of DexCom and Gambles the Proceeds on This Stock24/7 Wall Street • 01/11/25
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdownCNBC • 12/24/24
Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Convergent TV Ad EngagementBusiness Wire • 12/19/24
DXCM Stock Gains on the Launch of Proprietary Generative AI PlatformZacks Investment Research • 12/18/24
Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levelsCNBC • 12/17/24
Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGMBusiness Wire • 12/17/24